Francisco J Esteva Selected Research

Francisco J Esteva Research Topics

Disease

138	Breast Neoplasms (Breast Cancer) 04/2024 - 04/2002
79	Neoplasms (Cancer) 02/2024 - 06/2002
8	Disease Progression 12/2018 - 04/2002
8	Neoplasm Metastasis (Metastasis) 01/2018 - 07/2002
6	Cardiotoxicity 10/2021 - 09/2006
5	Neutropenia 01/2021 - 01/2017
4	Triple Negative Breast Neoplasms 10/2018 - 03/2010
4	Carcinoma (Carcinomatosis) 03/2015 - 01/2007
4	Carcinogenesis 10/2014 - 12/2008
4	Pathologic Complete Response 04/2014 - 08/2005
3	Thrombocytopenia (Thrombopenia) 10/2020 - 07/2002
3	Brain Neoplasms (Brain Tumor) 01/2018 - 07/2014
3	Noninfiltrating Intraductal Carcinoma (DCIS) 02/2014 - 01/2007
3	Residual Neoplasm 12/2009 - 08/2004
2	Pain (Aches) 12/2020 - 06/2018
2	Fatigue 12/2020 - 01/2019
2	Stomach Neoplasms (Stomach Cancer) 10/2019 - 08/2018
2	Insulin Resistance 01/2019 - 01/2013
2	Hyperinsulinism (Hyperinsulinemia) 01/2019 - 07/2014
2	Overweight 01/2019 - 01/2013
2	Febrile Neutropenia 01/2019 - 01/2017
2	Heart Failure 10/2018 - 07/2014
2	Ductal Carcinoma 04/2016 - 10/2014
2	Lymphatic Metastasis 06/2012 - 05/2012
2	Inflammatory Breast Neoplasms 11/2009 - 10/2006
2	Ovarian Neoplasms (Ovarian Cancer) 12/2008 - 09/2005

Drug/Important Bio-Agent (IBA)

63	Trastuzumab (Herceptin)FDA Link 10/2020 - 04/2002
20	Proteins (Proteins, Gene)FDA Link 12/2018 - 08/2002
19	ErbB Receptors (EGF Receptor)IBA 03/2024 - 01/2004
17	human ERBB2 proteinIBA 04/2024 - 01/2003
16	Hormones (Hormone)IBA 01/2021 - 10/2003
15	Monoclonal AntibodiesIBA 01/2023 - 06/2003
14	AnthracyclinesIBA 10/2021 - 04/2002
11	Doxorubicin (Adriamycin)FDA LinkGeneric 05/2009 - 06/2002
10	Biomarkers (Surrogate Marker)IBA 02/2018 - 06/2002
10	Lapatinib (GW572016)FDA Link 10/2015 - 11/2005
9	Estrogen ReceptorsIBA 10/2018 - 07/2004
7	Estrogens (Estrogen)FDA Link 01/2019 - 07/2003
7	Taxoids (Taxanes)IBA 08/2017 - 09/2003
7	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2009 - 06/2002
6	taxaneIBA 10/2020 - 09/2003
6	Tyrosine Kinase InhibitorsIBA 03/2015 - 06/2003
6	Docetaxel (Taxotere)FDA Link 04/2014 - 04/2002
6	Fluorouracil (Carac)FDA LinkGeneric 01/2007 - 06/2002
5	ribociclibIBA 12/2020 - 01/2018
5	Everolimus FDA Link 01/2019 - 10/2007
5	Progesterone Receptors (Progesterone Receptor)IBA 10/2018 - 10/2003
5	Paclitaxel (Taxol)FDA LinkGeneric 08/2017 - 05/2004
4	Immunoconjugates (Immunoconjugate)IBA 02/2024 - 01/2009
4	Biosimilar PharmaceuticalsIBA 10/2019 - 01/2017
4	pertuzumabIBA 08/2017 - 04/2004
4	Epidermal Growth Factor (EGF)IBA 08/2017 - 12/2008
4	Phosphotransferases (Kinase)IBA 03/2015 - 01/2003
4	Growth Factor ReceptorsIBA 02/2010 - 01/2003
4	Antisense OligonucleotidesIBA 12/2008 - 10/2003
3	Ado-Trastuzumab EmtansineIBA 02/2024 - 10/2015
3	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 02/2024 - 01/2004
3	Fulvestrant (Faslodex)FDA Link 12/2020 - 01/2018
3	Letrozole (Femara)FDA LinkGeneric 01/2019 - 06/2018
3	Metformin (Glucophage)FDA LinkGeneric 01/2019 - 01/2013
3	Cyclin-Dependent Kinases (cdk Proteins)IBA 01/2019 - 07/2004
3	MicroRNAs (MicroRNA)IBA 02/2018 - 05/2012
3	Messenger RNA (mRNA)IBA 02/2014 - 01/2007
3	Tamoxifen FDA LinkGeneric 02/2012 - 05/2005
3	IGF Type 1 Receptor (IGF 1 Receptor)IBA 02/2010 - 12/2005
3	Tumor Biomarkers (Tumor Markers)IBA 12/2008 - 10/2002
3	ParaffinIBA 05/2005 - 11/2003
2	Linoleic Acid (Linoleate)IBA 12/2020 - 08/2019
2	CT-P6IBA 10/2019 - 01/2017
2	TOR Serine-Threonine KinasesIBA 01/2019 - 10/2005
2	exemestane (Aromasin)FDA Link 01/2019 - 01/2013
2	Cytotoxins (Cytolysins)IBA 10/2018 - 01/2015
2	RNA (Ribonucleic Acid)IBA 02/2018 - 01/2017
2	AntibodiesIBA 02/2014 - 04/2004
2	Transcription Factors (Transcription Factor)IBA 11/2012 - 12/2005
2	Carboplatin (JM8)FDA LinkGeneric 07/2012 - 06/2002
2	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 05/2012 - 05/2005
2	Erlotinib Hydrochloride (CP 358,774)FDA Link 02/2012 - 11/2009
2	Antineoplastic Agents (Antineoplastics)IBA 12/2010 - 06/2006
2	TensinsIBA 10/2010 - 01/2009
2	DNA (Deoxyribonucleic Acid)IBA 03/2010 - 08/2008
2	Capecitabine (Xeloda)FDA Link 02/2010 - 09/2003
2	Neuregulin-1 (Neuregulin 1)IBA 01/2010 - 08/2002
2	Plasminogen Activators (Plasminogen Activator)IBA 12/2008 - 01/2004
2	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 12/2008 - 01/2004
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 12/2008 - 05/2006
2	PlatinumIBA 01/2007 - 06/2002
2	Formaldehyde (Formol)FDA Link 05/2005 - 07/2004
1	trastuzumab deruxtecanIBA 02/2024
1	IntegrinsIBA 01/2021

Therapy/Procedure

69	Therapeutics 04/2024 - 04/2002
34	Drug Therapy (Chemotherapy) 01/2019 - 04/2002
17	Neoadjuvant Therapy 03/2024 - 06/2002
5	Adjuvant Chemotherapy 12/2019 - 02/2004
3	Mastectomy (Mammectomy) 04/2024 - 05/2007
3	Biological Therapy 01/2019 - 01/2003
2	Immunotherapy 01/2019 - 01/2017
2	Combination Drug Therapy (Combination Chemotherapy) 04/2010 - 02/2006
2	Radiotherapy 04/2009 - 01/2007
1	Drug Tapering 01/2021